Finance

Beta
Lists
NVCT:NASDAQ
Nuvectis Pharma Inc
$10.71
+1.90%
(+0.20) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
$10.51
High
$10.80
Low
$10.11
Mkt. cap
284.09M
Avg. vol.
106.52K
Volume
69.10K
52-wk high
$13.34
52-wk low
$5.55
EPS
-$1.31
Beta
-0.07
Shares outstanding
26.53M
No. of employees
12
Open
$10.51
High
$10.80
Low
$10.11
Mkt. cap
284.09M
Avg. vol.
106.52K
Volume
69.10K
52-wk high
$13.34
52-wk low
$5.55
EPS
-$1.31
Beta
-0.07
Shares outstanding
26.53M
No. of employees
12
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to NVCT in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current $10.71
$17.00 (+58.73%)
Average
$15.00 (+40.06%)
Lowest
$13.00 (+21.38%)
News stories
From sources across the web
About Nuvectis Pharma Inc
CEO-
Employees12
Founded2020
HeadquartersFort Lee, New Jersey, United States
SectorBiotechnology
Websitenuvectis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.61M
5.77M
5.09M
4.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.98M
2.02M
2.53M
2.15M
Operating expense
6.60M
7.79M
7.62M
6.26M
Total operating expenses
6.60M
7.79M
7.62M
6.26M
Operating income
-6.60M
-7.79M
-7.62M
-6.26M
Other non operating income
-
-
-
-
EBT including unusual items
-6.33M
-7.46M
-7.31M
-6.05M
EBT excluding unusual items
-6.33M
-7.46M
-7.31M
-6.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.33M
-7.46M
-7.31M
-6.05M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
261.00K
332.00K
303.00K
210.00K
Interest expense
-
-
-
-
Net interest expenses
261.00K
332.00K
303.00K
210.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer